Compound Detail
CHEMBL190509
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
Basic Information
| ChEMBL ID | CHEMBL190509 |
| Phase | Preclinical |
| Structure Type | MOL |
| InChI Key | VZEJRFREYPGBOV-UHFFFAOYSA-N |
1
Targets
1
Activities
1
Assay Types
0
PK Parameters
1
Publications
0
Known Names
Molecular Properties
335.4
MW (Da)
3.04
ALogP
4
HBA
0
HBD
36.4
PSA (Ų)
0.86
QED
0
Ro5 Violations
4
Rot. Bonds
Drug Information
| Molecule Type | Small molecule |
| Availability | Unknown |
| Chirality | Unknown |
Activity Summary
Ki 1 meas. best 6.54
Target Activity Profile
| Target | Type | Best pChEMBL | Mean pChEMBL | Best (nM) | # Data |
|---|---|---|---|---|---|
| Unchecked CHEMBL612545 | Ki | 6.54 | 6.54 | 288.4 | 1 |
Activity Data Samples
Top measurements by pChEMBL value
| Target | Type | Rel. | Value | Units | pChEMBL | Assay | PubMed |
|---|---|---|---|---|---|---|---|
| Unchecked | Ki | = | 288.4 | nM | 6.54 | Inhibitory constant towards 5-hydroxytryptamine 2A receptor (5-HT2A) | 15878662 |
Literature References
| PubMed | DOI | Target Context | # Activities |
|---|---|---|---|
| 15878662 | 10.1016/j.bmcl.2005.04.022 | Unchecked | 3 |
Data from ChEMBL 36 via Core Engine